List of Tables
Table 1. Global Nuclear Medicine/Radiopharmaceuticals Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Nuclear Medicine/Radiopharmaceuticals Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Nuclear Medicine/Radiopharmaceuticals Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Nuclear Medicine/Radiopharmaceuticals Covered in This Study
Table 5. Global Nuclear Medicine/Radiopharmaceuticals Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Nuclear Medicine/Radiopharmaceuticals Sales Share by Manufacturers (2016-2021)
Table 7. Global Nuclear Medicine/Radiopharmaceuticals Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Nuclear Medicine/Radiopharmaceuticals Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Nuclear Medicine/Radiopharmaceuticals Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Nuclear Medicine/Radiopharmaceuticals Manufacturing Sites and Area Served
Table 11. Manufacturers Nuclear Medicine/Radiopharmaceuticals Product Type
Table 12. Global Nuclear Medicine/Radiopharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Nuclear Medicine/Radiopharmaceuticals by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nuclear Medicine/Radiopharmaceuticals as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Nuclear Medicine/Radiopharmaceuticals Sales by Region (2016-2021) & (K Units)
Table 16. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Region (2016-2021)
Table 17. Global Nuclear Medicine/Radiopharmaceuticals Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Nuclear Medicine/Radiopharmaceuticals Sales by Country (2016-2021) & (K Units)
Table 19. North America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Country (2016-2021)
Table 20. North America Nuclear Medicine/Radiopharmaceuticals Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Country (2016-2021)
Table 22. Europe Nuclear Medicine/Radiopharmaceuticals Sales by Country (2016-2021) & (K Units)
Table 23. Europe Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Country (2016-2021)
Table 24. Europe Nuclear Medicine/Radiopharmaceuticals Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Region (2016-2021)
Table 30. Latin America Nuclear Medicine/Radiopharmaceuticals Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Country (2016-2021)
Table 32. Latin America Nuclear Medicine/Radiopharmaceuticals Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Country (2016-2021)
Table 38. Global Nuclear Medicine/Radiopharmaceuticals Sales (K Units) by Type (2016-2021)
Table 39. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type (2016-2021)
Table 40. Global Nuclear Medicine/Radiopharmaceuticals Revenue (Million US$) by Type (2016-2021)
Table 41. Global Nuclear Medicine/Radiopharmaceuticals Revenue Share by Type (2016-2021)
Table 42. Global Nuclear Medicine/Radiopharmaceuticals Price (USD/Unit) by Type (2016-2021)
Table 43. Global Nuclear Medicine/Radiopharmaceuticals Sales (K Units) by Application (2016-2021)
Table 44. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2016-2021)
Table 45. Global Nuclear Medicine/Radiopharmaceuticals Revenue (Million US$) by Application (2016-2021)
Table 46. Global Nuclear Medicine/Radiopharmaceuticals Revenue Share by Application (2016-2021)
Table 47. Global Nuclear Medicine/Radiopharmaceuticals Price (USD/Unit) by Application (2016-2021)
Table 48. China Isotope & Radiation Corporation Information
Table 49. China Isotope & Radiation Description and Business Overview
Table 50. China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Product
Table 52. China Isotope & Radiation Recent Developments/Updates
Table 53. Dongcheng Corporation Information
Table 54. Dongcheng Description and Business Overview
Table 55. Dongcheng Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. Dongcheng Nuclear Medicine/Radiopharmaceuticals Product
Table 57. Dongcheng Recent Developments/Updates
Table 58. Jaco Corporation Information
Table 59. Jaco Description and Business Overview
Table 60. Jaco Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. Jaco Nuclear Medicine/Radiopharmaceuticals Product
Table 62. Jaco Recent Developments/Updates
Table 63. Ciaeriar Corporation Information
Table 64. Ciaeriar Description and Business Overview
Table 65. Ciaeriar Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. Ciaeriar Nuclear Medicine/Radiopharmaceuticals Product
Table 67. Ciaeriar Recent Developments/Updates
Table 68. Advanced Molecular-imaging Solution Corporation Information
Table 69. Advanced Molecular-imaging Solution Description and Business Overview
Table 70. Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Product
Table 72. Advanced Molecular-imaging Solution Recent Developments/Updates
Table 73. Shanghai Atom Kexing Corporation Information
Table 74. Shanghai Atom Kexing Description and Business Overview
Table 75. Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 76. Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Product
Table 77. Shanghai Atom Kexing Recent Developments/Updates
Table 78. Production Base and Market Concentration Rate of Raw Material
Table 79. Key Suppliers of Raw Materials
Table 80. Nuclear Medicine/Radiopharmaceuticals Distributors List
Table 81. Nuclear Medicine/Radiopharmaceuticals Customers List
Table 82. Nuclear Medicine/Radiopharmaceuticals Market Trends
Table 83. Nuclear Medicine/Radiopharmaceuticals Growth Drivers
Table 84. Nuclear Medicine/Radiopharmaceuticals Market Restraints
Table 85. Global Nuclear Medicine/Radiopharmaceuticals Sales Forecast by Type (2022-2027) & (K Units)
Table 86. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share Forecast by Type (2022-2027)
Table 87. Global Nuclear Medicine/Radiopharmaceuticals Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 88. Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share Forecast by Type (2022-2027)
Table 89. Global Nuclear Medicine/Radiopharmaceuticals Sales Forecast by Application (2022-2027) & (K Units)
Table 90. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share Forecast by Application (2022-2027)
Table 91. Global Nuclear Medicine/Radiopharmaceuticals Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 92. Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share Forecast by Application (2022-2027)
Table 93. Global Nuclear Medicine/Radiopharmaceuticals Sales Forecast by Region (2022-2027) & (K Units)
Table 94. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share Forecast by Region (2022-2027)
Table 95. Global Nuclear Medicine/Radiopharmaceuticals Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 96. Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share Forecast by Region (2022-2027)
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Nuclear Medicine/Radiopharmaceuticals
Figure 2. Global Nuclear Medicine/Radiopharmaceuticals Market Share by Type in 2020 & 2027
Figure 3. Diagnostic Product Picture
Figure 4. Therapeutic Product Picture
Figure 5. Global Nuclear Medicine/Radiopharmaceuticals Market Share by Application in 2020 & 2027
Figure 6. Oncology
Figure 7. Thyroid
Figure 8. Cardiology
Figure 9. Global Nuclear Medicine/Radiopharmaceuticals Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Nuclear Medicine/Radiopharmaceuticals Market Size 2016-2027 (US$ Million)
Figure 11. Global Nuclear Medicine/Radiopharmaceuticals Sales 2016-2027 (K Units)
Figure 12. Global Nuclear Medicine/Radiopharmaceuticals Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. Nuclear Medicine/Radiopharmaceuticals Sales Share by Manufacturers in 2020
Figure 14. Global Nuclear Medicine/Radiopharmaceuticals Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Nuclear Medicine/Radiopharmaceuticals Players: Market Share by Revenue in 2020
Figure 16. Nuclear Medicine/Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Region (2016-2021)
Figure 18. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Region in 2020
Figure 19. Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Region (2016-2021)
Figure 20. Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Region in 2020
Figure 21. U.S. Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. U.K. Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Taiwan Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Philippines Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Vietnam Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Mexico Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Brazil Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Argentina Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Turkey Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Saudi Arabia Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. U.A.E Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Sales Market Share of Nuclear Medicine/Radiopharmaceuticals by Type (2016-2021)
Figure 46. Sales Market Share of Nuclear Medicine/Radiopharmaceuticals by Application (2016-2021)
Figure 47. Sales Market Share of Nuclear Medicine/Radiopharmaceuticals by Application in 2020
Figure 48. Revenue Share of Nuclear Medicine/Radiopharmaceuticals by Application (2016-2021)
Figure 49. Revenue Share of Nuclear Medicine/Radiopharmaceuticals by Application in 2020
Figure 50. Manufacturing Cost Structure of Nuclear Medicine/Radiopharmaceuticals
Figure 51. Manufacturing Process Analysis of Nuclear Medicine/Radiopharmaceuticals
Figure 52. Nuclear Medicine/Radiopharmaceuticals Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed

LIST OF FIGURE